[ad_1] Another reason for the trial’s failure could be that exenatide is much less potent than its newer cousin semaglutide, better known as Ozempic. Now that Ozempic is everywhere, anecdotal…
[ad_1] Another reason for the trial’s failure could be that exenatide is much less potent than its newer cousin semaglutide, better known as Ozempic. Now that Ozempic is everywhere, anecdotal…